STAR

Strides Pharma Science Share PriceStrides Pharma Science

₹302.00
2.3 (0.77%)
As on 08 February, 2023 | 08:20 BSE: 532531 NSE: STAR

Strides Pharma Science Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Strides Pharma Science

Start SIP

Strides Pharma Science Share Price

  • Over 1 Month -14.12%
  • Over 3 Month -7.81%
  • Over 6 Month -12.6%
  • Over 1 Year -22.5%

Strides Pharma Science Key Statistics

P/E Ratio -16.6
PEG Ratio -0.3
Market Cap Cr 2,727
Price to Book Ratio 1.1
EPS 19.5
Dividend 0
Relative Strength Index 38.27
Money Flow Index 25.38
MACD Signal -11.83
Average True Range 13.39

Strides Pharma Science Investment Rating

  • Master Rating:
  • Strides Pharma Science has an operating revenue of Rs. 3,568.03 Cr. on a trailing 12-month basis. An annual revenue de-growth of -5% needs improvement, Pre-tax margin of -18% needs improvement, ROE of -19% is poor and needs improvement. The company has a reasonable debt to equity of 35%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 52 which is a POOR score indicating inconsistency in earnings, a RS Rating of 35 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 95 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Strides Pharma Science Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 387481423456
Operating Expenses Qtr Cr 341487484438
Operating Profit Qtr Cr 46-6-6118
Depreciation Qtr Cr 22242424
Interest Qtr Cr 35352622
Tax Qtr Cr 5-40-38-144
Net Profit Qtr Cr 13-4-66201

Strides Pharma Science Technicals

EMA & SMA

Current Price
₹302.
2.3 (0.77%)
  • Bullish Moving Average
  • ___
  • 2
  • Bearish Moving Average
  • ___
  • 14
  • 20 Day
  • 316.3
  • 50 Day
  • 329.73
  • 100 Day
  • 333.66
  • 200 Day
  • 352.72
  • 20 Day
  • 319.27
  • 50 Day
  • 342.13
  • 100 Day
  • 330.92
  • 200 Day
  • 329.14

Strides Pharma Science Resistance and Support

PIVOT
₹298.04
Resistance
First Resistance 302.97
Second Resistance 306.24
Third Resistance 311.17
RSI 38.28
MFI 25.38
MACD Single Line -11.83
MACD -13.51
Support
First Resistance 294.77
Second Resistance 289.84
Third Resistance 286.57

Strides Pharma Science Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 171,084 5,363,483 31.35
Week 521,549 20,444,721 39.2
1 Month 397,915 14,157,812 35.58
6 Month 509,977 19,384,211 38.01

Strides Pharma Science Result Highlights

Strides Pharma Science Synopsis

NSE-Medical-Generic Drugs

Strides Pharma Scien is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1979.00 Cr. and Equity Capital is Rs. 89.79 Cr. for the Year ended 31/03/2022. Strides Pharma Science Ltd. is a Public Limited Listed company incorporated on 28/06/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1990PLC057062 and registration number is 057062.
Market Cap 2,727
Sales 1,747
Shares in Float 6.23
No of funds 116
Yield 0.36
Book Value 0.8
U/D Vol ratio 1
LTDebt / Equity 4
Alpha -0.08
Beta 1.33

Strides Pharma Science

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 30.89%31.07%30.37%
Mutual Funds 11.65%8.32%9.81%
Insurance Companies 5.26%5.26%
Foreign Portfolio Investors 18.98%21.43%21.21%
Financial Institutions/ Banks 0.01%0.01%0.01%
Individual Investors 22.43%22.4%22.29%
Others 10.78%11.51%16.31%

Strides Pharma Science Management

Name Designation
Mr. Arun Kumar Exe.Chairman & Mng.Director
Mr. Badree Komandur Executive Director & Group CFO
Mr. Deepak Vaidya Non Executive Director
Dr. Kausalya Santhanam Independent Director
Mr. Bharat D Shah Independent Director
Mr. Homi Rustam Khusrokhan Independent Director
Mr. S Sridhar Independent Director

Strides Pharma Science Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Strides Pharma Science MF Shareholding

Name Amount(cr)
Aditya Birla Sun Life Flexi Cap Fund Growth 16192
SBI Long Term Equity Fund Regular Payout of Income Distribution cum capital wdrl 12092
Aditya Birla Sun Life Equity Advantage Fund Growth 5216
Aditya Birla Sun Life Pure Value Fund Growth 4037
Quant Active Fund Growth 3480

Strides Pharma Science FAQs

What is Share Price of Strides Pharma Science ?

Strides Pharma Science share price is ₹302 As on 08 February, 2023 | 08:06

What is the Market Cap of Strides Pharma Science ?

The Market Cap of Strides Pharma Science is ₹2727.1 Cr As on 08 February, 2023 | 08:06

What is the P/E ratio of Strides Pharma Science ?

The P/E ratio of Strides Pharma Science is -16.6 As on 08 February, 2023 | 08:06

What is the PB ratio of Strides Pharma Science ?

The PB ratio of Strides Pharma Science is 1.1 As on 08 February, 2023 | 08:06

Q2FY23